• 100% of patients receiving Head and Neck radiotherapy.^1,2
• Up to 100% of patients undergoing high-dose chemotherapy with hematopoietic stem cell transplantation.^3,4
• 30-75% of patients receiving chemotherapy.¹

 Neoplasias associated with an incidence of severe (grade 3 and 4) mucositis.

Reference:
1. Epstein, Schubert. Oncology 2003; 17:1767-82;
2. Peterson et al. Ann Oncol 2009; 20(supp4):174-7;
3. Sonis. J Support Oncol 2004; 2(6 suppl 3):3-8;
4. Silverman. J Support Oncol 2007; 2(2 Suppl 1):13-21